Jyothy Labs

Jyothy Labs reported Q4 FY26 revenue of ₹717 croreCurrent reported value: ₹717 crore. No comparable prior figure is available in the source record., up 7.7% YoYCurrent reported value: 7.7% YoY. No comparable prior figure is available in the source record., driven by strong volume growth of 17.8%Current 17.8%. Reported change: +17.8pp YoY. in fabric care and 20%Current 20%. Reported change: +20pp YoY. in personal care. However, EBITDA margin contracted 330 bpsCurrent reported value: 330 bps. No comparable prior figure is available in the source record. to 13.5%Current reported value: 13.5%. No comparable prior figure is available in the source record. due to sharp input cost inflation (crude-linked raw materials up 60-65%) and lower realizations from competitive pricing and grammage increases. Management highlighted near-term margin pressure and declined to provide FY27 guidance. The company took selective price hikes of ~4% in March, with full impact expected from Q2. Key risks include sustained crude price volatility and inability to fully pass on costs in a competitive environment. The household insecticides segment is nearing breakeven, with liquid vaporizer now 55%Current 55%. Reported change: +5pp YoY. of the portfolio.